ZBD | $40,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Asymmetric Security | $4,200,000 | (Jan 23, 2026)
CorWave
France
- Clichy, Île-de-France
- 21/06/2023
- Series C
- $28,414,360
CorWave is a medical device company developing innovative heart pumps (Left Ventricular Assist Devices, LVADs).
Our mission is to lower the burden associated with LVADs by curbing pump-related adverse events and reducing the invasiveness of the surgery. We are leveraging a unique and patented pumping technology that overcomes the drawbacks of rotary pump systems. Inspired by nature, CorWave technology can mimic the native heart blood flow pattern (low shear and pulsatile), reduces energy-requirements and gives opportunities to downsize LVADs further.
CorWave was founded in 2012 by MD Start and received funding from top-tier investors including Ysios, Sofinnova, Seventure, Medtronic, Novo and Bpifrance.
- Industry Medical Equipment Manufacturing
- Website https://www.corwave.com/
- LinkedIn https://www.linkedin.com/company/corwave/
Related People
Louis de LillersFounder
France -
ND
Entrepreneur on a mission to improve the lives of heart failure patients as CEO of CorWave. Passionate about hardware startups.
Cubby | $63,000,000 | (Jan 23, 2026)
Cambio | $18,000,000 | (Jan 23, 2026)
Cork Protocol | $5,500,000 | (Jan 23, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)
Mendra | $82,000,000 | (Jan 23, 2026)
Artie Technologies | $12,000,000 | (Jan 23, 2026)
Antidote Legal | $5,000,000 | (Jan 23, 2026)
One to One Health | $12,000,000 | (Jan 22, 2026)